Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 920.01 Million | 866.72 Million | 809.78 Million | 808.64 Million | 1.06 Billion | 1.02 Billion |
| Cost of Revenue | 101.04 Million | 126.15 Million | 105.75 Million | 59.24 Million | 57.66 Million | 50.04 Million |
| Gross Profit | 818.96 Million | 740.56 Million | 704.02 Million | 749.39 Million | 1 Billion | 972.11 Million |
| Operating Expenses | 675.67 Million | 603.34 Million | 571.23 Million | 600.75 Million | 766.93 Million | 708.32 Million |
| Selling, General and Administrative Expenses | 512.16 Million | 456.3 Million | 423.48 Million | 497.98 Million | 645.87 Million | 616.52 Million |
| Research and Development Expenses | 94.91 Million | 86.77 Million | 102.26 Million | 93.1 Million | 108.78 Million | 80.24 Million |
| Other Expenses | 68.59 Million | 60.26 Million | 45.48 Million | 9.66 Million | 12.27 Million | 175.28 Thousand |
| Cost and Expenses | 776.72 Million | 729.49 Million | 676.99 Million | 660 Million | 824.59 Million | 758.36 Million |
| Operating Income | 143.28 Million | 140.7 Million | 192.29 Million | 210.22 Million | 299.51 Million | 300.03 Million |
| Interest Expense | 2.42 Million | 864.06 Thousand | 1.4 Million | 418.41 Thousand | 27.21 Thousand | 35.11 Million |
| Income Tax Expense | -64.83 Million | 16.42 Million | 21.41 Million | 24.66 Million | 33.01 Million | 36.28 Million |
| Earnings before Tax | 122.73 Million | 140.31 Million | 188.85 Million | 208.02 Million | 299.09 Million | 300.21 Million |
| Net Income | 150.45 Million | 101.49 Million | 147.98 Million | 183.35 Million | 266.08 Million | 263.92 Million |
| Earnings Per Share Basic | 0.96 | 0.65 | 0.94 | 1.15 | 1.66 | 1.98 |
| Earnings Per Share Diluted | 0.96 | 0.65 | 0.94 | 1.15 | 1.66 | 1.98 |
| Weighted Average Shares Outstanding | 156.71 Million | 156.49 Million | 157.43 Million | 160 Million | 160 Million | 133.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 156.71 Million | 156.49 Million | 157.43 Million | 160 Million | 160 Million | 133.29 Million |
| Gross Margin | 0.89 | 0.85 | 0.87 | 0.93 | 0.95 | 0.95 |
| EBIT Margin | 0.20 | 0.21 | 0.28 | 0.29 | 0.27 | 0.30 |
| Profit Margin | 0.16 | 0.12 | 0.18 | 0.23 | 0.25 | 0.26 |
| EBITDA | 188.49 Million | 189.96 Million | 226.09 Million | 238.85 Million | 240.23 Million | 334.78 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.24 | 0.26 | 0.28 | 0.29 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 239.55 Million | 203.66 Million | 199.23 Million | 920.01 Million | 199.97 Million | 269.2 Million |
| Cost of Revenue | 26.32 Million | 25.19 Million | 22.45 Million | 101.04 Million | 27.82 Million | 25.73 Million |
| Gross Profit | 213.22 Million | 178.46 Million | 176.77 Million | 818.96 Million | 172.15 Million | 243.46 Million |
| Operating Expenses | 173.5 Million | 140.54 Million | 128.07 Million | 776.72 Million | 245.21 Million | 176.02 Million |
| Selling, General and Administrative Expenses | 161.75 Million | 130.26 Million | 116.61 Million | - | 97.36 Million | 181.03 Million |
| Research and Development Expenses | 11.74 Million | 10.27 Million | 11.31 Million | - | 27.69 Million | 26.93 Million |
| Other Expenses | - | -291.73 Thousand | 418.27 | -776.72 Million | -245.21 Million | 2.44 Million |
| Cost and Expenses | 199.82 Million | 165.73 Million | 150.53 Million | 776.72 Million | 245.21 Million | 201.76 Million |
| Operating Income | 39.72 Million | 37.92 Million | 50.26 Million | 143.28 Million | -45.24 Million | 67.88 Million |
| Interest Expense | 1.73 Million | 1.24 Million | 1.23 Million | 2.78 Million | 1.55 Million | 613.59 Thousand |
| Income Tax Expense | 7.16 Million | 10.1 Million | 3.41 Million | -27.71 Million | -52.65 Million | 8.41 Million |
| Earnings before Tax | 42.6 Million | 51.1 Million | 50.26 Million | 122.73 Million | -65.04 Million | 67.88 Million |
| Net Income | 33.77 Million | 37.54 Million | 41.65 Million | 150.45 Million | -12.38 Million | 55.74 Million |
| Earnings Per Share Basic | 0.21 | 0.24 | 0.27 | - | -0.08 | 0.36 |
| Earnings Per Share Diluted | 0.21 | 0.24 | 0.27 | - | -0.08 | 0.36 |
| Weighted Average Shares Outstanding | 158.98 Million | 158.98 Million | 154.27 Million | 156.71 Million | 157.41 Million | 156.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 158.98 Million | 158.98 Million | 154.27 Million | 156.71 Million | 157.41 Million | 156.49 Million |
| Gross Margin | 0.89 | 0.88 | 0.89 | 0.89 | 0.86 | 0.90 |
| EBIT Margin | 0.19 | 0.23 | 0.25 | - | -0.24 | 0.27 |
| Profit Margin | 0.14 | 0.18 | 0.21 | 0.16 | -0.06 | 0.21 |
| EBITDA | 44.33 Million | 47.61 Million | 50.45 Million | - | -47.17 Million | 72.86 Million |
| Earnings Before Tax Margin | 0.17 | 0.19 | 0.25 | 0.16 | -0.23 | 0.25 |
VMC
605080
7314
KALYANI
ALLUX
DWVYF